Company History

Since 1980, we have analyzed more than 600 compounds to identify a promising compound for development as a cancer treatment for 30 years and developed new compound, As4O6, CHEMAS was established in 2000 and we are taking a step to obtain approval from relevant authorities for TetraAs.

chemas_history
2013 ~
2016.02 Commence clinical trials in Europe
2016.01 Join in partnership with Korean medical doctors of Korean Medicine CHEMAS Network and educate about CHEMAS’s arsenic compounds
2013 ~ Finish pre-clinical trials and start process of new drug registration in China
2001 ~ 2008
2008 Conclude LOI with CRO for the process of clinical trial in Europe
2007 Obtain permission of phase II clinical trial
2000 ~ 2004 International application filed with PCT receiving office and national patent office.
2004 ~ 2005 Phase 1 Clinical trials
2001 ~ 2002 Pre-clinical trials
1980 ~ 2000
1998 ~ 2000 Patent registration relating to manufacture of TetraAs
1997 ~ 1999 Completed tests on efficacy and toxicity of new compound
1989 ~ 1994 Treat a number of patients with terminal cancer with new compound
1980 ~ 1996 Research and development of new compound to develop anti-cancer drug
Search